
Different therapies or drugs are used to slow or stop the growth of neuroendocrine cancer cells. Close to half of NET patients report using drug therapy other than chemotherapy.2 About 1 in 5 patients were treated with chemotherapy.2
Somatostatin Analogs
Hormone therapy with a somatostatin analog may stop an excess of hormones from being made, which can improve people’s quality of life with relatively mild adverse effects.23 Side effects include nausea, cramping, loose stools, abnormal stools (steatorrhea), and changes in heart rate.24 Somatostatin analogs are available in long- and short-acting formulations, delivered by injection.